cox-2 inhibitor

(redirected from COX-2 selective inhibitor)
Also found in: Dictionary, Thesaurus, Medical.
Related to COX-2 selective inhibitor: Coxib

cox-2 inhibitor:

see nonsteroidal anti-inflammatory drugnonsteroidal anti-inflammatory drug,
a drug that suppresses inflammation in a manner similar to steroids, but without the side effects of steroids; commonly referred to by the acronym NSAID .
..... Click the link for more information.
References in periodicals archive ?
Last year's study of 336,906 community-dwelling Medicaid beneficiaries by the Veterans Affairs Tennessee Valley Healthcare System extended concerns about COX-2 selective inhibitors to cerebrovascular disease, said Dr.
They found that there were significantly fewer upper gastrointestinal clinical events with the COX-2 selective inhibitor etoricoxib than with the traditional NSAID diclofenac due to a decrease in uncomplicated events, but not in the more serious complicated events.
Commenting on the trial data presented at EULAR, Dr JE[micro]rg Reinhardt, Head of Development, Novartis Pharma AG, said: "This body of data confirms that Prexige is an efficacious COX-2 selective inhibitor which could offer substantial benefit to patients with osteoarthritis.
Justification for the Development of COX-2 Selective Inhibitors
Cox-2 Selective Inhibitors and Acute Myocardial Infarction - Beta-Blockers, increased bone formation, decreased risk of hip and vertebral fractures - Antidepressant Use and Suicidality in Pediatric Patients - Isotretinoin, Pregnancies, Abortions, and Birth Defects - Late Pregnancy Use of Selective Serotonin Reuptake Inhibitors and Risk for Persistent Pulmonary Hypertension in Newborns - Antiepileptic Drugs and Risk of Fractures - Trends in Prescribing of Antipsychotic Medications for US Children - Antihypertensive Therapy after ALLHAT: Are More Patients Starting with Diuretics?
The data suggest that "people who use low-dose aspirin for heart protection should take COX-2 selective inhibitors rather than nonselective NSAIDs for treatment of arthritis and musculoskeletal pain," Dr.
This therapeutic product candidate has the potential to fulfill the need for an effective, tolerable and safer alternative to either oral non-selective NSAIDs or COX-2 selective inhibitors for the treatment of osteoarthritis of the knee, as well as other diseases and disorders which are associated with localized pain and inflammation.
for Arcoxia than for any other NSAID, including traditional NSAIDs and COX-2 selective inhibitors," Dr.